Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | NPX372 |
| Synonyms | |
| Therapy Description |
NPX372 is a bispecific antibody targeting B7-H7, which may lead to activation of anti-tumor immune response (J Immunother Cancer 2024; 12 (Suppl 2):1318). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| NPX372 | NPX 372|NPX-372 | NPX372 is a bispecific antibody targeting B7-H7, which may lead to activation of anti-tumor immune response (J Immunother Cancer 2024; 12 (Suppl 2):1318). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07563829 | Phase I | NPX372 | NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies | Not yet recruiting | USA | 0 |